Trial intelligence / Profile preview

Dexmedetomidine vs sufentanil as adjuvants to bupivacaine in dynamic hip screw surgery

IRCT2017050220258N45Phase 3Completed

Sponsor
Arak University of Medical Sciences
Start
Apr 2016
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of dexmedetomidine, sufentanil and bupivacaine in hip fracture (2 arms), sponsored by Arak University of Medical Sciences. Started Apr 2016; status: completed.

02

Drugs

dexmedetomidinesufentanilbupivacaine
03

Conditions

hip fracture

Beyond the preview

Go deeper on IRCT2017050220258N45.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2017050220258N45.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call